Pfizer and Amazon Web Services are just another example of how artificial intelligence is working in the background in healthcare.
Biotechnology is a booming industry recently focused on synthetic biology, biomanufacturing and gene editing. Biotech is seen as the key to the future, as it has the potential to cure diseases and save many lives. In fact, the global biotechnology market is currently valued at $1.22 trillion and is expected to grow to $3.21 trillion by 2030. That shows a possible compound annual growth rate of 12.8%. In comparison, the S&P 500 has a growth rate of 9.51% per year. Plus, biotech industry revenue i
Amid some rising questions for the economy, value-seeking investors may want to consider underappreciated biotech stocks. As a sector that, while not immune to broader pressures, generally manages to march to its own beat, the underlying innovation may offer an alternative upside pathway. By now, you’ve likely heard about the impressive third-quarter U.S. GDP print, which came in hotter than expected. But looking ahead, circumstances don’t seem so rosy to justify belief in a repeat performance.